Liu, Chia-Chen http://orcid.org/0000-0001-7203-3926
Wang, Na
Chen, Yuanxin
Inoue, Yasuteru
Shue, Francis
Ren, Yingxue
Wang, Minghui
Qiao, Wenhui
Ikezu, Tadafumi C.
Li, Zonghua
Zhao, Jing http://orcid.org/0000-0002-4520-6307
Martens, Yuka
Doss, Sydney V. http://orcid.org/0000-0002-3427-4654
Rosenberg, Cassandra L.
Jeevaratnam, Suren
Jia, Lin
Raulin, Ana-Caroline
Qi, Fangfang
Zhu, Yiyang
Alnobani, Alla
Knight, Joshua
Chen, Yixing
Linares, Cynthia
Kurti, Aishe
Fryer, John D. http://orcid.org/0000-0003-3390-2994
Zhang, Bin
Wu, Long-Jun http://orcid.org/0000-0001-8019-3380
Kim, Betty Y. S. http://orcid.org/0000-0001-6890-8355
Bu, Guojun http://orcid.org/0000-0003-3491-1016
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (AG027924, AG069701, AG062110, AG062110, AG069701)
Cure Alzheimer’s Fund
BrightFocus Foundation (A20201542S)
Article History
Received: 4 November 2022
Accepted: 6 September 2023
First Online: 19 October 2023
Competing interests
: During the initial phase of these studies, G.B. consulted for SciNeuro, AbbVie, E-Scape, Vida Ventures and Eisai, and was on the scientific advisory board for Kisbee Therapeutics. G.B. was an employee of SciNeuro during the revision phase and is currently employed at Hong Kong University of Science and Technology. C.-C.L. was employed with Biogen during the revision phase and is currently an employee of Biogen. Y.M. is currently an employee of SciNeuro. The other authors declare no competing interests.